UNSPSC 51342708: Interferon alfa-n1

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47BPR3V3MP. European Medicines Agency schedules Interferon alfa-n1 in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20625. As of Q4 2014, INTERFERON ALFA-N1 remains the US FDA Preferred Term for this commodity. Interferon alfa-n1 bears US NLM identifiers UMLS ID C0699817 and NCI Concept Code C2220. SMILES: NONE.

UNSPSC 51342708 Interferon alfa-n1, a Commodity code, nominally describes a specific immunological therapeutic agent, but recent state and local contract activity under this code shows little alignment with interferon procurement. The two recent opportunities tagged to the code cover pharmaceutical warehouse distribution agreements and naloxone/drug deactivation system purchases — neither directly related to interferon alfa-n1 as a pharmaceutical product line. This mismatch suggests the code either is rarely used for its intended scope in state and local procurement, or recent opportunities have been mislabeled in the sourcing system. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate and Ciprofloxacin Hydrochloride totaling $2,999,999.11 over three years. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Neither procurement involves interferon alfa-n1.

Recent activity under the code shows sparse and inconsistent issuing patterns — only two opportunities in the source, with one being a completed award rather than an open solicitation, and the second unrelated to the code's stated scope. Geographic presence is limited to Illinois and Florida based on these records. Without concrete evidence of active state or local procurement demand for interferon alfa-n1 specifically, this code presents minimal signal for vendors specializing in that therapeutic category. Business development professionals should verify whether this code remains actively used for interferon procurement in their target jurisdictions before committing resources to pursuit.